Altmetrics
Downloads
104
Views
59
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Preprints on COVID-19 and SARS-CoV-2
Period Quarter/year | Admission | Pt on ABX | % | PTZ DDD | PTZ ACI | MER DDD | MER ACI | VANC DDD | VANC ACI | CFT DDD | CFT ACI |
---|---|---|---|---|---|---|---|---|---|---|---|
I/2018 | 16,668 | 916 | 5.5 | 3883 | 38.8 | 1580 | 15.8 | 655 | 6.6 | 2353 | 23.5 |
II/2018 | 15,501 | 809 | 5.2 | 4365 | 43.7 | 3185 | 31.9 | 638 | 6.4 | 1928 | 19.3 |
III/2018 | 15,987 | 864 | 5.4 | 5626 | 56.3 | 1610 | 16.1 | 642 | 6.4 | 1985 | 19.9 |
IV/2018 | 17,360 | 980 | 5.6 | 6275 | 62.8 | 1699 | 17 | 718 | 7.2 | 2148 | 21.5 |
I/2019 | 16,955 | 871 | 5.1 | 3884 | 38.8 | 1154 | 11.5 | 601 | 6 | 1804 | 18 |
II/2019 | 16,192 | 917 | 5.7 | 5540 | 55.4 | 2812 | 28.1 | 669 | 6.7 | 1704 | 17 |
III/2019 | 16,537 | 945 | 5.7 | 5931 | 59.3 | 1399 | 14 | 624 | 6.2 | 1948 | 19.5 |
IV2019 | 17,628 | 1048 | 5.9 | 7231 | 72.3 | 1519 | 15.2 | 729 | 7.3 | 2399 | 24 |
Total pre-COVID | 132,828 | 7350 | 5.53 | 42,735 | 14,958 | 5276 | 16,269 | ||||
Median (IQR) ACI | 56 (41–61) | 16 (14–23) | 7 (6–10) | 20 (19–23) | |||||||
I/2020 | 16,362 | 1204 | 7.4 | 5573 | 55.7 | 1278 | 12.8 | 799 | 8 | 2532 | 25.3 |
II/2020 | 11,743 | 831 | 7.1 | 3777 | 37.8 | 1443 | 14.4 | 739 | 7.4 | 2407 | 24.1 |
III/2020 | 13,665 | 891 | 6.5 | 4947 | 49.5 | 2142 | 21.4 | 1333 | 13.3 | 1882 | 18.8 |
IV/2020 | 14,933 | 886 | 5.9 | 4356 | 43.6 | 1894 | 18.9 | 1116 | 11.2 | 2381 | 23.8 |
I/2021 | 16,001 | 894 | 5.6 | 5588 | 55.9 | 1393 | 13.9 | 879 | 8.8 | 1944 | 19.4 |
II/2021 | 14,545 | 1064 | 7.3 | 5356 | 53.6 | 2176 | 21.8 | 1271 | 12.7 | 3160 | 31.6 |
III/2021 | 15,201 | 1044 | 6.9 | 6865 | 68.7 | 1986 | 19.9 | 1128 | 11.3 | 2446 | 24.5 |
IV/2021 | 16,741 | 1101 | 6.6 | 5283 | 52.8 | 1814 | 18.1 | 980 | 9.8 | 2488 | 24.9 |
Total COVID | 119,191 | 7915 | 6.64 | 41,745 | 14,126 | 8245 | 19,240 | ||||
Median (IQR) ACI | 53 (47–56) | 19 (14–21) | 11 (8–12) | 24 (22–25) | |||||||
p-value | 0.528 | 0.834 | 0.001 | 0.036 |
Period | Pre – COVID | COVID | p - value | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | 2019 | 2020 | Median | 2021 | 2022 | Median | |||||||||||||
Quarter | I | II | III | IV | I | II | III | IV | I | II | III | IV | I | II | III | IV | |||
MRSA | 174 | 150 | 173 | 170 | 170 | 154 | 176 | 162 | 170 | 143 | 115 | 117 | 143 | 130 | 147 | 153 | 178 | 143 | 0.016 |
CRE | 150 | 148 | 113 | 138 | 119 | 143 | 115 | 104 | 129 | 161 | 93 | 128 | 122 | 133 | 151 | 209 | 170 | 142 | 0.208 |
VRE | 4 | 4 | 1 | 3 | 4 | 2 | 3 | 1 | 3 | 2 | 2 | 10 | 7 | 35 | 86 | 227 | 184 | 23 | 0.026 |
MDRPA | 18 | 8 | 7 | 1 | 3 | 2 | 7 | 4 | 6 | 6 | 3 | 2 | 3 | 4 | 1 | 1 | 0 | 3 | 0.072 |
MDRAB | 35 | 18 | 24 | 45 | 36 | 25 | 9 | 2 | 25 | 14 | 5 | 28 | 34 | 5 | 49 | 42 | 20 | 24 | 1.000 |
ESBL | 121 | 135 | 143 | 173 | 127 | 175 | 216 | 190 | 158 | 202 | 124 | 177 | 190 | 158 | 208 | 205 | 177 | 184 | 0.189 |
C. auris | 0 | 0 | 0 | 2 | 0 | 0 | 3 | 20 | 0 | 36 | 14 | 17 | 28 | 23 | 19 | 10 | 17 | 18 | 0.004 |
Period | Pre – COVID | COVID | p - value | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | 2019 | 2020 | Median | 2021 | 2022 | Median | ||||||||||||||||
Quarter | I | II | III | IV | I | II | III | IV | ||||||||||||||
Sample | Blood culture | |||||||||||||||||||||
MRSA | 4 | 2 | 8 | 6 | 5 | 4 | 8 | 12 | 6 | 10 | 7 | 10 | 12 | 5 | 6 | 14 | 12 | 10 | 0.057 | |||
CRE | 21 | 17 | 9 | 9 | 11 | 17 | 15 | 5 | 13 | 19 | 15 | 21 | 13 | 19 | 13 | 13 | 15 | 15 | 0.266 | |||
VRE | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 2 | 3 | 22 | 12 | 4 | 4 | 0.061 | |||
MDRPA | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.927 | |||
MDRAB | 6 | 1 | 3 | 3 | 7 | 1 | 2 | 1 | 3 | 3 | 2 | 5 | 1 | 1 | 4 | 9 | 2 | 3 | 0.748 | |||
ESBL | 21 | 25 | 33 | 34 | 28 | 25 | 38 | 25 | 27 | 31 | 31 | 42 | 20 | 16 | 37 | 35 | 30 | 31 | 0.598 | |||
C. auris | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 4 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0.565 | |||
Sample | Urine culture | |||||||||||||||||||||
MRSA | 1 | 2 | 3 | 2 | 1 | 2 | 4 | 4 | 2 | 2 | 2 | 1 | 3 | 2 | 4 | 3 | 3 | 2.5 | 0.743 | |||
CRE | 16 | 16 | 10 | 26 | 16 | 18 | 10 | 16 | 16 | 29 | 11 | 22 | 24 | 28 | 31 | 29 | 27 | 28 | 0.011 | |||
VRE | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 2 | 1 | 5 | 3 | 8 | 10 | 38 | 22 | 6.5 | 0.002 | |||
MDRPA | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 5 | 0.46 | |||
MDRAB | 7 | 3 | 7 | 12 | 7 | 8 | 3 | 1 | 7 | 3 | 1 | 3 | 5 | 0 | 5 | 5 | 2 | 3 | 0.062 | |||
ESBL | 88 | 98 | 97 | 131 | 88 | 131 | 170 | 154 | 115 | 164 | 83 | 104 | 129 | 124 | 141 | 138 | 130 | 130 | 0.752 | |||
C. auris | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 6 | 4 | 3 | 1 | 0 | 2 | 0.03 | |||
Sample | Endotracheal secretion culture | |||||||||||||||||||||
MRSA | 6 | 2 | 9 | 5 | 6 | 1 | 2 | 3 | 4 | 3 | 4 | 8 | 6 | 16 | 13 | 5 | 6 | 6 | 0.112 | |||
CRE | 10 | 15 | 9 | 11 | 10 | 11 | 6 | 4 | 10 | 9 | 5 | 21 | 22 | 11 | 8 | 23 | 13 | 12 | 0.268 | |||
VRE | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n/i | |||
MDRPA | 15 | 8 | 7 | 1 | 3 | 0 | 4 | 3 | 4 | 3 | 2 | 2 | 2 | 4 | 0 | 1 | 0 | 2 | 0.09 | |||
MDRAB | 11 | 7 | 7 | 15 | 11 | 8 | 2 | 0 | 7 | 4 | 1 | 10 | 14 | 2 | 20 | 14 | 8 | 3 | 0.673 | |||
ESBL | 9 | 10 | 11 | 6 | 9 | 15 | 5 | 11 | 10 | 7 | 10 | 31 | 39 | 18 | 30 | 32 | 16 | 24 | 0.018 | |||
C. auris | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0.143 | |||
Sample | Screening | |||||||||||||||||||||
MRSA | 163 | 144 | 153 | 157 | 158 | 147 | 162 | 143 | 155 | 128 | 102 | 98 | 122 | 107 | 124 | 131 | 157 | 123 | 0.004 | |||
CRE | 103 | 100 | 85 | 92 | 82 | 97 | 84 | 79 | 89 | 104 | 62 | 64 | 63 | 75 | 99 | 144 | 115 | 87 | 0.834 | |||
VRE | 3 | 3 | 1 | 1 | 3 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 24 | 54 | 177 | 158 | 13 | 0.121 | |||
MDRPA | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.317 | |||
MDRAB | 63 | 58 | 64 | 56 | 52 | 41 | 41 | 26 | 54 | 33 | 15 | 28 | 26 | 17 | 44 | 47 | 42 | 31 | 0.031 | |||
ESBL | 3 | 2 | 2 | 2 | 2 | 4 | 3 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0.005 | |||
C. auris | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 15 | 0 | 33 | 14 | 14 | 21 | 18 | 16 | 9 | 16 | 16 | 0.002 |
Piperacillin tazobactam | Meropenem | Vancomycin | Ceftriaxone | |||||
---|---|---|---|---|---|---|---|---|
Microorganism | rho | p - value | rho | p - value | rho | p - value | rho | p - value |
MRSA | 0.25 | 0.351 | -0.1 | 0.716 | -0.56 | 0.025 | -0.05 | 0.85 |
CRE | 0.06 | 0.816 | -0.38 | 0.144 | 0.39 | 0.14 | 0.36 | 0.165 |
VRE | -0.16 | 0.565 | 0.32 | 0.229 | 0.58 | 0.017 | 0.18 | 0.495 |
MDR PA | -0.12 | 0.665 | -0.35 | 0.182 | -0.61 | 0.013 | -0.27 | 0.321 |
MDR AB | -0.11 | 0.684 | 0.4 | 0.124 | 0.19 | 0.484 | 0.05 | 0.867 |
ESBL | 0.57 | 0.021 | 0.15 | 0.579 | 0.46 | 0.075 | 0.42 | 0.102 |
C. auris | 0.17 | 0.539 | -0.2 | 0.468 | 0.71 | 0.002 | 0.56 | 0.023 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Submitted:
22 September 2023
Posted:
22 September 2023
You are already at the latest version
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Preprints on COVID-19 and SARS-CoV-2
Submitted:
22 September 2023
Posted:
22 September 2023
You are already at the latest version
Period Quarter/year | Admission | Pt on ABX | % | PTZ DDD | PTZ ACI | MER DDD | MER ACI | VANC DDD | VANC ACI | CFT DDD | CFT ACI |
---|---|---|---|---|---|---|---|---|---|---|---|
I/2018 | 16,668 | 916 | 5.5 | 3883 | 38.8 | 1580 | 15.8 | 655 | 6.6 | 2353 | 23.5 |
II/2018 | 15,501 | 809 | 5.2 | 4365 | 43.7 | 3185 | 31.9 | 638 | 6.4 | 1928 | 19.3 |
III/2018 | 15,987 | 864 | 5.4 | 5626 | 56.3 | 1610 | 16.1 | 642 | 6.4 | 1985 | 19.9 |
IV/2018 | 17,360 | 980 | 5.6 | 6275 | 62.8 | 1699 | 17 | 718 | 7.2 | 2148 | 21.5 |
I/2019 | 16,955 | 871 | 5.1 | 3884 | 38.8 | 1154 | 11.5 | 601 | 6 | 1804 | 18 |
II/2019 | 16,192 | 917 | 5.7 | 5540 | 55.4 | 2812 | 28.1 | 669 | 6.7 | 1704 | 17 |
III/2019 | 16,537 | 945 | 5.7 | 5931 | 59.3 | 1399 | 14 | 624 | 6.2 | 1948 | 19.5 |
IV2019 | 17,628 | 1048 | 5.9 | 7231 | 72.3 | 1519 | 15.2 | 729 | 7.3 | 2399 | 24 |
Total pre-COVID | 132,828 | 7350 | 5.53 | 42,735 | 14,958 | 5276 | 16,269 | ||||
Median (IQR) ACI | 56 (41–61) | 16 (14–23) | 7 (6–10) | 20 (19–23) | |||||||
I/2020 | 16,362 | 1204 | 7.4 | 5573 | 55.7 | 1278 | 12.8 | 799 | 8 | 2532 | 25.3 |
II/2020 | 11,743 | 831 | 7.1 | 3777 | 37.8 | 1443 | 14.4 | 739 | 7.4 | 2407 | 24.1 |
III/2020 | 13,665 | 891 | 6.5 | 4947 | 49.5 | 2142 | 21.4 | 1333 | 13.3 | 1882 | 18.8 |
IV/2020 | 14,933 | 886 | 5.9 | 4356 | 43.6 | 1894 | 18.9 | 1116 | 11.2 | 2381 | 23.8 |
I/2021 | 16,001 | 894 | 5.6 | 5588 | 55.9 | 1393 | 13.9 | 879 | 8.8 | 1944 | 19.4 |
II/2021 | 14,545 | 1064 | 7.3 | 5356 | 53.6 | 2176 | 21.8 | 1271 | 12.7 | 3160 | 31.6 |
III/2021 | 15,201 | 1044 | 6.9 | 6865 | 68.7 | 1986 | 19.9 | 1128 | 11.3 | 2446 | 24.5 |
IV/2021 | 16,741 | 1101 | 6.6 | 5283 | 52.8 | 1814 | 18.1 | 980 | 9.8 | 2488 | 24.9 |
Total COVID | 119,191 | 7915 | 6.64 | 41,745 | 14,126 | 8245 | 19,240 | ||||
Median (IQR) ACI | 53 (47–56) | 19 (14–21) | 11 (8–12) | 24 (22–25) | |||||||
p-value | 0.528 | 0.834 | 0.001 | 0.036 |
Period | Pre – COVID | COVID | p - value | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | 2019 | 2020 | Median | 2021 | 2022 | Median | |||||||||||||
Quarter | I | II | III | IV | I | II | III | IV | I | II | III | IV | I | II | III | IV | |||
MRSA | 174 | 150 | 173 | 170 | 170 | 154 | 176 | 162 | 170 | 143 | 115 | 117 | 143 | 130 | 147 | 153 | 178 | 143 | 0.016 |
CRE | 150 | 148 | 113 | 138 | 119 | 143 | 115 | 104 | 129 | 161 | 93 | 128 | 122 | 133 | 151 | 209 | 170 | 142 | 0.208 |
VRE | 4 | 4 | 1 | 3 | 4 | 2 | 3 | 1 | 3 | 2 | 2 | 10 | 7 | 35 | 86 | 227 | 184 | 23 | 0.026 |
MDRPA | 18 | 8 | 7 | 1 | 3 | 2 | 7 | 4 | 6 | 6 | 3 | 2 | 3 | 4 | 1 | 1 | 0 | 3 | 0.072 |
MDRAB | 35 | 18 | 24 | 45 | 36 | 25 | 9 | 2 | 25 | 14 | 5 | 28 | 34 | 5 | 49 | 42 | 20 | 24 | 1.000 |
ESBL | 121 | 135 | 143 | 173 | 127 | 175 | 216 | 190 | 158 | 202 | 124 | 177 | 190 | 158 | 208 | 205 | 177 | 184 | 0.189 |
C. auris | 0 | 0 | 0 | 2 | 0 | 0 | 3 | 20 | 0 | 36 | 14 | 17 | 28 | 23 | 19 | 10 | 17 | 18 | 0.004 |
Period | Pre – COVID | COVID | p - value | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | 2019 | 2020 | Median | 2021 | 2022 | Median | ||||||||||||||||
Quarter | I | II | III | IV | I | II | III | IV | ||||||||||||||
Sample | Blood culture | |||||||||||||||||||||
MRSA | 4 | 2 | 8 | 6 | 5 | 4 | 8 | 12 | 6 | 10 | 7 | 10 | 12 | 5 | 6 | 14 | 12 | 10 | 0.057 | |||
CRE | 21 | 17 | 9 | 9 | 11 | 17 | 15 | 5 | 13 | 19 | 15 | 21 | 13 | 19 | 13 | 13 | 15 | 15 | 0.266 | |||
VRE | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 2 | 3 | 22 | 12 | 4 | 4 | 0.061 | |||
MDRPA | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.927 | |||
MDRAB | 6 | 1 | 3 | 3 | 7 | 1 | 2 | 1 | 3 | 3 | 2 | 5 | 1 | 1 | 4 | 9 | 2 | 3 | 0.748 | |||
ESBL | 21 | 25 | 33 | 34 | 28 | 25 | 38 | 25 | 27 | 31 | 31 | 42 | 20 | 16 | 37 | 35 | 30 | 31 | 0.598 | |||
C. auris | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 4 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0.565 | |||
Sample | Urine culture | |||||||||||||||||||||
MRSA | 1 | 2 | 3 | 2 | 1 | 2 | 4 | 4 | 2 | 2 | 2 | 1 | 3 | 2 | 4 | 3 | 3 | 2.5 | 0.743 | |||
CRE | 16 | 16 | 10 | 26 | 16 | 18 | 10 | 16 | 16 | 29 | 11 | 22 | 24 | 28 | 31 | 29 | 27 | 28 | 0.011 | |||
VRE | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 2 | 1 | 5 | 3 | 8 | 10 | 38 | 22 | 6.5 | 0.002 | |||
MDRPA | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 5 | 0.46 | |||
MDRAB | 7 | 3 | 7 | 12 | 7 | 8 | 3 | 1 | 7 | 3 | 1 | 3 | 5 | 0 | 5 | 5 | 2 | 3 | 0.062 | |||
ESBL | 88 | 98 | 97 | 131 | 88 | 131 | 170 | 154 | 115 | 164 | 83 | 104 | 129 | 124 | 141 | 138 | 130 | 130 | 0.752 | |||
C. auris | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 6 | 4 | 3 | 1 | 0 | 2 | 0.03 | |||
Sample | Endotracheal secretion culture | |||||||||||||||||||||
MRSA | 6 | 2 | 9 | 5 | 6 | 1 | 2 | 3 | 4 | 3 | 4 | 8 | 6 | 16 | 13 | 5 | 6 | 6 | 0.112 | |||
CRE | 10 | 15 | 9 | 11 | 10 | 11 | 6 | 4 | 10 | 9 | 5 | 21 | 22 | 11 | 8 | 23 | 13 | 12 | 0.268 | |||
VRE | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n/i | |||
MDRPA | 15 | 8 | 7 | 1 | 3 | 0 | 4 | 3 | 4 | 3 | 2 | 2 | 2 | 4 | 0 | 1 | 0 | 2 | 0.09 | |||
MDRAB | 11 | 7 | 7 | 15 | 11 | 8 | 2 | 0 | 7 | 4 | 1 | 10 | 14 | 2 | 20 | 14 | 8 | 3 | 0.673 | |||
ESBL | 9 | 10 | 11 | 6 | 9 | 15 | 5 | 11 | 10 | 7 | 10 | 31 | 39 | 18 | 30 | 32 | 16 | 24 | 0.018 | |||
C. auris | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0.143 | |||
Sample | Screening | |||||||||||||||||||||
MRSA | 163 | 144 | 153 | 157 | 158 | 147 | 162 | 143 | 155 | 128 | 102 | 98 | 122 | 107 | 124 | 131 | 157 | 123 | 0.004 | |||
CRE | 103 | 100 | 85 | 92 | 82 | 97 | 84 | 79 | 89 | 104 | 62 | 64 | 63 | 75 | 99 | 144 | 115 | 87 | 0.834 | |||
VRE | 3 | 3 | 1 | 1 | 3 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 24 | 54 | 177 | 158 | 13 | 0.121 | |||
MDRPA | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.317 | |||
MDRAB | 63 | 58 | 64 | 56 | 52 | 41 | 41 | 26 | 54 | 33 | 15 | 28 | 26 | 17 | 44 | 47 | 42 | 31 | 0.031 | |||
ESBL | 3 | 2 | 2 | 2 | 2 | 4 | 3 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0.005 | |||
C. auris | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 15 | 0 | 33 | 14 | 14 | 21 | 18 | 16 | 9 | 16 | 16 | 0.002 |
Piperacillin tazobactam | Meropenem | Vancomycin | Ceftriaxone | |||||
---|---|---|---|---|---|---|---|---|
Microorganism | rho | p - value | rho | p - value | rho | p - value | rho | p - value |
MRSA | 0.25 | 0.351 | -0.1 | 0.716 | -0.56 | 0.025 | -0.05 | 0.85 |
CRE | 0.06 | 0.816 | -0.38 | 0.144 | 0.39 | 0.14 | 0.36 | 0.165 |
VRE | -0.16 | 0.565 | 0.32 | 0.229 | 0.58 | 0.017 | 0.18 | 0.495 |
MDR PA | -0.12 | 0.665 | -0.35 | 0.182 | -0.61 | 0.013 | -0.27 | 0.321 |
MDR AB | -0.11 | 0.684 | 0.4 | 0.124 | 0.19 | 0.484 | 0.05 | 0.867 |
ESBL | 0.57 | 0.021 | 0.15 | 0.579 | 0.46 | 0.075 | 0.42 | 0.102 |
C. auris | 0.17 | 0.539 | -0.2 | 0.468 | 0.71 | 0.002 | 0.56 | 0.023 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated